EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS161-04019 
Organism
Homo sapiens 
Tissue/cell
PC3 
Coordinate
chr12:109249370-109251200 
Target genes
Number: 6             
NameEnsembl ID
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs987044chr12109250356hg19
Number of super-enhancer constituents: 35             
IDCoordinateTissue/cell
SE_00113chr12:109244424-109251439Adipose_Nuclei
SE_01037chr12:109249271-109251865Adrenal_Gland
SE_01623chr12:109246181-109252083Aorta
SE_02246chr12:109246168-109252078Astrocytes
SE_04650chr12:109249244-109251148Brain_Anterior_Caudate
SE_06218chr12:109246114-109251372Brain_Hippocampus_Middle
SE_08617chr12:109249226-109251457Brain_Inferior_Temporal_Lobe
SE_09493chr12:109247147-109253018CD14
SE_25830chr12:109244536-109251201Duodenum_Smooth_Muscle
SE_26704chr12:109246214-109251864Esophagus
SE_29719chr12:109249196-109251365Fetal_Muscle
SE_32104chr12:109249273-109251984Gastric
SE_34450chr12:109246280-109252128HCT-116
SE_34725chr12:109245953-109252240HeLa
SE_36100chr12:109246988-109251401HMEC
SE_36924chr12:109244176-109251762HSMMtube
SE_37947chr12:109244148-109252158HUVEC
SE_38903chr12:109246069-109251429IMR90
SE_40657chr12:109245919-109253030Left_Ventricle
SE_42149chr12:109245912-109252798Lung
SE_44139chr12:109246155-109251395NHDF-Ad
SE_44751chr12:109244532-109252762NHLF
SE_45545chr12:109244280-109252952Osteoblasts
SE_47346chr12:109244433-109251321Panc1
SE_48097chr12:109245995-109252101Psoas_Muscle
SE_48602chr12:109245944-109251883Right_Atrium
SE_49578chr12:109249348-109251413Right_Ventricle
SE_50432chr12:109246119-109251878Sigmoid_Colon
SE_51142chr12:109244391-109251449Skeletal_Muscle
SE_51706chr12:109246219-109251409Skeletal_Muscle_Myoblast
SE_52666chr12:109246054-109251874Small_Intestine
SE_53376chr12:109245391-109252770Spleen
SE_63492chr12:109246142-109251594HSMM
SE_65195chr12:109247561-109251325NHEK
SE_68566chr12:109231845-109256560TC71
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr12109249389109249909
chr12109250000109250362
Enhancer Sequence
CTGACAGGTT CAGCCTGAAG CCAACCTCTC CCCTTACCTC ACATAAACTT TTGTGATGAG 60
AACCTGAGAT TAAGTGCATA AATTGCCAGA CAGCAGTGAC CGGAACAGAA AACAGCCCCT 120
CCTCGCTGTG GGAAGGAAAG GCGCTCCTGC AACCTAACTT CTCAGTAGCA GGCTATTGAT 180
CGCCAGTGTT CTTTTGCCTC TAATCAGCGT GTAGAGGGGG ATTACTAGAA CCTTCTGTGT 240
ATAGATAACT CATGAATGGC CTCTCCTCTC CAAGGAGGGG GCTGTGAAGG TTCAACTTCC 300
CAGCCACTCT GAAAATGTCC CTGCCAATCC CAGCAAAACA AGGCTGAAGA ACTACCCTAC 360
CAGGAGACAG GGCTGTCAAG CCAAATGCAA ACATTATTCT CTTGTCTCTC TCAGACACAC 420
AAACCTCCCC CGTGTTATCA GTCAACTTCC CCCACTCCCT CCCACAAAGA AAGGGGCTGA 480
AGAGCCCAGA TGCTGGCTGC GGAACTTCCT GGGCCTGGGA CCGCAGGGCC GCTCCTCCAG 540
TCTTCTCTAA ACACAGCTAA GGGTCTGCAG GCGGACACTC AGCCTTGTTA TAGGTAAGAG 600
TTTAGACCAG AGGCCTTGAC GGGTTCTTCA AGAGATGGTG GGCAAGATTG CGCGACCAGA 660
GGGTCATCCC TGCAGCTACA GAGGGCTGAC CTGCTCAGAG GCCCAAGGCC CCAGCCTAGG 720
ACAAGCCAGG CCAACCCTGC AGGCTAAGAG GGCAACAGTG CCCTCAATCA ACCCCAGAGG 780
AAAAAGTGGC CAGGCAAACG GACCTGGGCC ACACACAGAC CCACAAAAAC GCGCACAGTG 840
CCAGGACACG CAACCCAGGA ATGCACCTAT GCAATCACCC AGAATGGGTC ACAGCCACAC 900
AGAAAGATAG ATGCACATAA ACACACAGGC CTGAGTGATG TTACAGAAAG GAAAAGCCAG 960
ACTAAGGCTG CACGCACAGA CGTGAAACAC AGCCACACAG AGCCCACAGC ACGCTCGGTC 1020
ACCGTCACAC AGTGACACGG GCACGCCTAC AGACAGAACT CCAGAGGCGG CAGGCGGGGA 1080
AACAATCTCA CACGTTTGTA GGGGCACTCC CAGATGCCTG TCTCACGCTG GCACAGTCCC 1140
CGGACGGCAG GTCAGCAACA GTCACATCTC ACATCGCACA GCCAGGCATA CAGGCAAAGG 1200
GCCTAGAACT ACCCCGGCCA CAGGTCTCAG AACCAGCGGC TCACGCAGTC ACCCAATCAA 1260
GGGTCCCAGT TGCACATCCA GTCACCCCTG GACCCTGGTC ACACTGCAGA GTCACTCACA 1320
AATGGGAGTC CCGACAGACG CACAGTCCTC CCCAGACAGA GGTCAACCCA AGATGGGGGT 1380
CACACCTGAA ATCACAGTCC CCACACAATC ACGAGGTCAC ATCTGCACAC ACAGTCTCTG 1440
CACAGTCACC CTTAGGGGTC ACAACGCACA CAGTCTCCGC CTAACAGGGG TCACCCCAAG 1500
ATGGGGGTAA CCCCCTGATG TGGGTCACAG CGCACACACA GTATCCTGCA GACACTCCCA 1560
GAGGGGTCGC ACTGCATACA CAGTCCCTGC AAAGTCGCCC CCCGATAGGG GTCACACCGC 1620
ACACAAAGTC CCCGCACAGC TCCCCAAGAC AGGGTCACAT CGCACACAGT CCTCGCACGG 1680
TCACCCCGGT CCGGCTGCCC GGCTCTGTTC CTACGGCGGG GCCCCGAGGA GCCCGCGCAG 1740
CCGCCCCCCT GCCCCGCACG CGCGGCCCCA GCTCCGGCGG CCTCGGCGCG GCGTCCGGCG 1800
GCCCAGGCCG GGCGCGGCGA GCCCGGGGCT 1830